CLINICAL_TRIALS
trial_result
· 2018-11-07
Clinical Trial Update: Mirtazapine Treatment of Anxiety in Children and Adolescents With Pervasive Developmental Disorders [Phase 3]
Summary
Phase 3 trial evaluating mirtazapine for anxiety in children and adolescents with pervasive developmental disorders completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Autism Spectrum Disorders | Phase 3 | Status: COMPLETED | Results posted: 2018-11-07